skip to Main Content



CCDRD AG has extensive experience with generic Tiotropium product development compared to the reference product Spiriva®.

  • 20 pilot and pivotal trials performed with Tiotropium inhalers in healthy subjects
  • systemic safety and pulmonary deposition studies
  • highly experienced investigators and study teams in the phase I units available
  • standardized training and clinical procedures
  • intrasubject and residual variance data available
  • information about product aging available
Back To Top